ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Why RadNet (RDNT) Stock Is Up Today

RDNT Cover Image

What Happened?

Shares of diagnostic imaging company RadNet (NASDAQ: RDNT) jumped 3.4% in the afternoon session after the company presented a robust strategic outlook at the Barclays 28th Annual Global Healthcare Conference, projecting strong growth for 2026. 

During the event, CFO Mark Stolper highlighted RadNet's significant revenue and EBITDA growth in 2025, which was driven by strong performance in advanced imaging. The company projected 2026 revenue to grow by 17%-19% and EBITDA to increase by 18%-22%. This positive company-specific news was supported by favorable trends in the broader medical imaging industry. The AI-Enabled X-Ray Imaging Solutions market, where RadNet is a key player, was expected to expand significantly. This growth reflected the company's strategic investments in technology to enhance its services in a competitive market.

After the initial pop the shares cooled down to $61.51, up 2.9% from previous close.

Is now the time to buy RadNet? Access our full analysis report here, it’s free.

What Is The Market Telling Us

RadNet’s shares are quite volatile and have had 16 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 7 days ago when the stock dropped 6.5% on the news that the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses. 

According to the Bureau of Labor Statistics, the economy lost 92,000 nonfarm payroll jobs, a stark reversal from the 50,000 gain that was anticipated by economists. The healthcare sector, typically a consistent source of job growth, shed 28,000 positions. This disappointing data has raised investor concerns about a potential economic slowdown, which could lead to reduced healthcare spending and demand for services, contributing to the sector's decline in the market.

RadNet is down 13.3% since the beginning of the year, and at $61.51 per share, it is trading 27.2% below its 52-week high of $84.48 from November 2025. Investors who bought $1,000 worth of RadNet’s shares 5 years ago would now be looking at an investment worth $2,565.

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  207.67
-1.86 (-0.89%)
AAPL  250.12
-5.64 (-2.21%)
AMD  193.39
-4.35 (-2.20%)
BAC  46.72
-0.41 (-0.87%)
GOOG  301.46
-1.75 (-0.58%)
META  613.71
-24.47 (-3.83%)
MSFT  395.55
-6.31 (-1.57%)
NVDA  180.25
-2.89 (-1.58%)
ORCL  155.11
-4.05 (-2.54%)
TSLA  391.20
-3.81 (-0.96%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.